Ares Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-13,928
| Closed | -$180K | – | 38 |
|
|
2022
Q1 | $180K | Hold |
13,928
| – | – | 0.01% | 39 |
|
|
2021
Q4 | $222K | Hold |
13,928
| – | – | 0.01% | 44 |
|
|
2021
Q3 | $224K | Hold |
13,928
| – | – | 0.01% | 42 |
|
|
2021
Q2 | $193K | Hold |
13,928
| – | – | 0.01% | 43 |
|
|
2021
Q1 | $203K | Hold |
13,928
| – | – | 0.01% | 36 |
|
|
2020
Q4 | $242K | Hold |
13,928
| – | – | 0.01% | 32 |
|
|
2020
Q3 | $255K | Hold |
13,928
| – | – | 0.02% | 33 |
|
|
2020
Q2 | $249K | Hold |
13,928
| – | – | 0.01% | 31 |
|
|
2020
Q1 | $226K | Buy |
13,928
+2,500
| +22% | +$40.6K | 0.03% | 38 |
|
|
2019
Q4 | $206K | Hold |
11,428
| – | – | 0.02% | 47 |
|
|
2019
Q3 | $232K | Hold |
11,428
| – | – | 0.02% | 43 |
|
|
2019
Q2 | $253K | Hold |
11,428
| – | – | 0.02% | 41 |
|
|
2019
Q1 | $156K | Hold |
11,428
| – | – | 0.01% | 59 |
|
|
2018
Q4 | $103K | Buy |
+11,428
| New | +$103K | 0.01% | 72 |
|